BUSINESS● LOWAug 14 · Aug 14, 2026, 6:01 AM
Zentalis Pharmaceuticals slides after pricing 23M share public offering at $3.50/share
Seeking Alpha Tech
Zentalis Pharmaceuticals experienced a decline in stock value after pricing a public offering of 23 million shares at $3.50 per share. This event is significant for investors following the company's financial performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS17m agoN4,000/$ Exchange Rate: NDC asks why refineries are not workingVanguard NigeriaBUSINESS22m agoAt 50: Brand refresh raises questions about heritage, consumer loyaltyVanguard Nigeria